Investor Alert: Robbins LLP Informs Investors of the SelectQuote, Inc. Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly violating the False Claims Act by directing Medicare beneficiaries to plans that compensated the company rather than providing unbiased comparisons [1][2][3] Allegations - SelectQuote is accused of failing to disclose that it directed Medicare beneficiaries to plans based on compensation rather than quality [2] - The company allegedly did not provide unbiased comparison shopping for Medicare Advantage insurance plans [2] - SelectQuote is claimed to have received illegal kickbacks to steer beneficiaries towards certain insurers, limiting enrollment in competitors' plans [2] - The company is said to have violated applicable laws and regulations, making it vulnerable to regulatory and legal sanctions [2] - The U.S. Department of Justice filed a complaint alleging SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021 [3] Impact on Stock Price - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025 [3]